NCT00290706 2019-05-28A Phase I/II Trial of VELCADE & Gemcitabine for Patients With Relapsed or Refractory Aggressive B- and T-cell Non-Hodgkin's LymphomaNorthwestern UniversityPhase 1/2 Terminated32 enrolled 12 charts